Mindray Cancer Antigen 72-4 (CA72-4) CLIA Reagent Kit

Mindray Cancer Antigen 72-4 (CA72-4) CLIA Reagent Kit is an in vitro diagnostic reagent intended for the quantitative determination of Cancer Antigen 72-4 in human serum using compatible Mindray CL-series automated chemiluminescence immunoassay analyzers. Mindray officially includes CA72-4 in its tumor-marker CLIA test menu and supplies its CLIA reagents in liquid, ready-to-use formats. CA72-4 is a tumor-associated marker used as part of clinical evaluation and monitoring in oncology, particularly in gastrointestinal malignancies such as gastric cancer. It should not be used alone to diagnose cancer; results should be interpreted alongside clinical findings and other investigations. Key Features - Quantitative determination of Cancer Antigen 72-4 - Commonly identified as CA72-4 - Uses chemiluminescence immunoassay technology - Sandwich CLIA assay principle - Suitable for human serum - Compatible with Mindray CL-series immunoassay analyzers - Liquid, ready-to-use reagent format - Available in 2 × 50 tests and 2 × 100 tests - Reportable range of 0.2–300 U/mL - Measurement may extend to 600 U/mL with 2-fold dilution - Recommended refrigerated storage at 2–8°C - Intended for professional in vitro diagnostic use